Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. [electronic resource]
Producer: 20020212Description: 188-99 p. digitalISSN:- 0008-5472
- Activating Transcription Factor 1
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Benzamides -- pharmacology
- CDC2 Protein Kinase -- metabolism
- Cyclic AMP Response Element-Binding Protein -- metabolism
- DNA-Binding Proteins -- metabolism
- Down-Regulation -- drug effects
- Drug Synergism
- Enzyme Inhibitors -- pharmacology
- Fusion Proteins, bcr-abl -- biosynthesis
- G1 Phase -- drug effects
- HL-60 Cells -- drug effects
- Humans
- Imatinib Mesylate
- JNK Mitogen-Activated Protein Kinases
- K562 Cells -- drug effects
- MAP Kinase Kinase 1
- MAP Kinase Kinase 2
- MAP Kinase Kinase Kinases -- antagonists & inhibitors
- MAP Kinase Signaling System -- drug effects
- Milk Proteins
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Phosphorylation -- drug effects
- Piperazines -- pharmacology
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyrimidines -- pharmacology
- Resting Phase, Cell Cycle -- drug effects
- STAT5 Transcription Factor
- Trans-Activators -- metabolism
- Transcription Factors
- U937 Cells -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.